2016
DOI: 10.1016/j.amjcard.2015.12.051
|View full text |Cite
|
Sign up to set email alerts
|

Role of Vorapaxar After Coronary Revascularization

Abstract: Abstract:We aim to evaluate the potential benefit and risk of addition of vorapaxar to standard medical therapy in patients who underwent coronary revascularization with either percutaneous coronary revascularization (PCI) or coronary artery bypass graft surgery (CABG).We searched PubMed, EMBASE, the Cochrane Central Register of Controlled

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 14 publications
(17 reference statements)
0
0
0
Order By: Relevance